Related resources
Search for item elsewhere
University researcher(s)
Academic department(s)
Screening assays for binding antagonists of the AMD-associated variant of factor H (H384).
Anthony J. Day, Simon J. Clark, Paul N. Bishop, Robert B. Sim, Anna M. Blom, Dick Heinegard
University of Manchester, USPTO. 7829301. 2010 Sep 11..
Access to files
Full-text and supplementary files are not available from Manchester eScholar. Use our list of Related resources to find this item elsewhere. Alternatively, request a copy from the Library's Document supply service.
Abstract
The invention relates to identifying agents which have the ability to preferentially inhibit binding to targets such as heparin of the H384 allotypic variant of human complement Factor H, the allotypic variant associated with age-related macular degeneration (AMD), and the non-disease associated form of the same factor (Y384). The targets of interest show differential binding of the two allotypic variants and antagonists thus identified are of interest in developing treatments for AMD.